Insights from BCC Research

Laurie L. Sullivan

Recent Posts

Google Spin-Off Jumps Into the Wearable Device Game

Posted by Laurie L. Sullivan on Dec 28, 2017 11:45:00 AM

Smartwatch.jpg

Earlier this month, BCC Research hosted an event “Connected Medical Devices: Bridging the Gap Between Wearables and Clinical Applications” in Boston, MA. BCC Research Senior editors Michael Sullivan and Robert G. Hunter discussed the future of wearable medical devices, especially those that link clinical and consumer applications. In her blog post from August 2017, Laurie Sullivan writes about one Google spin-off coming ever closer to “bridging the gap.”

Read More

Topics: Life Sciences, Healthcare

Interest in Botanicals is Blossoming: Global Market Set to Grow By 50%

Posted by Laurie L. Sullivan on Dec 26, 2017 2:00:00 PM

Natural_Medicine.jpegThere has been increasing interest in botanical drugs, with many players investigating their commercial potential. According to BCC Research, the global market for plant-derived and botanical drugs is expected to reach $39.6 billion by 2022. Excluding botanicals, growth in the plant-derived drug market is in line with the overall pharmaceutical industry, given the presence of generics (including biosimilars). Patent expirations will necessitate medicinal compounds other than single chemical entities. Growth in the U.S. market for plant-derived drugs will reflect new cannabinoids and their overall expanded uses, as well as eventual brand line extensions.

Read More

Topics: Life Sciences, Biotechnology

3D Cell Culture: Global Markets and Out-of-this-World Applications

Posted by Laurie L. Sullivan on Dec 19, 2017 1:15:00 PM

3D_cells.jpegAhead of the January 2018 update on the report “3D Cell Cultures: Technologies and Global Markets,” we are resharing Laurie Sullivan’s blog from July. On January 24, 2018, the analyst Robert G. Hunter will present a Member Exclusive Webinar and Q&A session on this report. Purchase the report or become a Member to attend!

Read More

Topics: Life Sciences, Biotechnology

FDA Approves First Digital Pill in Growing Medication Adherence Market

Posted by Laurie L. Sullivan on Dec 11, 2017 11:00:00 AM

First Digital Pill.jpegA higher incidence of chronic diseases worldwide and the demand for advanced medication adherence systems are fueling growth in this market, which has the potential to surpass $3.9 billion by 2021. A new study by BCC Research examines the industry’s prospects and technologies by disease applications and geographical regions.

Read More

Topics: Life Sciences, Pharmaceuticals